These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22340179)

  • 21. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils.
    Massaro M; Scoditti E; Carluccio MA; Campana MC; De Caterina R
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):59-82. PubMed ID: 20196971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque disruption and thrombosis: potential role of inflammation and infection.
    Shah PK
    Cardiol Rev; 2000; 8(1):31-9. PubMed ID: 11174871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.
    Daissormont IT; Kraaijeveld AO; Biessen EA
    Future Cardiol; 2009 May; 5(3):273-84. PubMed ID: 19450053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokines and cardiovascular risk.
    Aukrust P; Halvorsen B; Yndestad A; Ueland T; Øie E; Otterdal K; Gullestad L; Damås JK
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1909-19. PubMed ID: 18669888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation.
    Wilensky RL; Hamamdzic D
    Curr Opin Cardiol; 2007 Nov; 22(6):545-51. PubMed ID: 17921743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation and cortisol response in coronary artery disease.
    Nijm J; Jonasson L
    Ann Med; 2009; 41(3):224-33. PubMed ID: 18979272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
    Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
    J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application.
    Blake GJ; Ridker PM
    Ital Heart J; 2001 Nov; 2(11):796-800. PubMed ID: 11770860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
    Tedgui A; Mallat Z
    Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and coronary artery disease.
    Tiong AY; Brieger D
    Am Heart J; 2005 Jul; 150(1):11-8. PubMed ID: 16084145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is any link between inflammation and coronary artery ectasia?
    Li JJ; Li Z; Li J
    Med Hypotheses; 2007; 69(3):678-83. PubMed ID: 17222519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammation and atherosclerosis].
    Tedgui A; Mallat Z
    Nephrologie; 2003; 24(7):411-4. PubMed ID: 14650755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The variable role of inflammation in acute coronary syndromes and in restenosis.
    Biasucci LM; Liuzzo G; Buffon A; Maseri A
    Semin Interv Cardiol; 1999 Sep; 4(3):105-10. PubMed ID: 10545616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery.
    Hollan I; Scott H; Saatvedt K; Prayson R; Mikkelsen K; Nossent HC; Kvelstad IL; Liang MH; Førre OT
    Arthritis Rheum; 2007 Jun; 56(6):2072-9. PubMed ID: 17530648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation and atherosclerosis in acute coronary syndromes.
    Murtagh BM; Anderson HV
    J Invasive Cardiol; 2004 Jul; 16(7):377-84. PubMed ID: 15282433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.